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Abstract The migration of polymorphonuclear granulo-
cytes (PMN) into the brain parenchyma and release of their
abundant proteases are considered the main causes of
neuronal cell death and reperfusion injury following
ischemia. Yet, therapies targeting PMN egress have been
largely ineffective. To address this discrepancy we inves-
tigated the temporo-spatial localization of PMNs early after
transient ischemia in a murine transient middle cerebral
artery occlusion (tMCAO) model and human stroke spec-
imens. Using specific markers that distinguish PMN
(Ly6G) from monocytes/macrophages (Ly6C) and that
define the cellular and basement membrane boundaries of
the neurovascular unit (NVU), histology and confocal
microscopy revealed that virtually no PMNs entered the
infarcted CNS parenchyma. Regardless of tMCAO
duration, PMNs were mainly restricted to luminal surfaces or
perivascular spaces of cerebral vessels. Vascular PMN
accumulation showed no spatial correlation with increased
vessel permeability, enhanced expression of endothelial cell
adhesion molecules, platelet aggregation or release of neu-
trophil extracellular traps. Live cell imaging studies
confirmed that oxygen and glucose deprivation followed by
reoxygenation fail to induce PMN migration across a brain
endothelial monolayer under flow conditions in vitro. The
absence of PMN infiltration in infarcted brain tissues was
corroborated in 25 human stroke specimens collected at early
time points after infarction. Our observations identify the
NVU rather than the brain parenchyma as the site of PMN
action after CNS ischemia and suggest reappraisal of targets
for therapies to reduce reperfusion injury after stroke.
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Introduction
Reperfusion of cerebral vessels after transient occlusion is
associated with immune cell recruitment, which contributes
to both damage of the vessel and the surrounding tissue.
Polymorphonuclear granulocytes (PMNs) are considered to
play a prominent role in microvascular responses to
ischemia via protease-mediated tissue damage and neuro-
nal cell death during reperfusion by direct contact with
CNS tissue [2, 7, 19, 39, 49, 60]. This necessitates PMN
extravasation across the blood–brain barrier (BBB) into the
brain parenchyma at early stages after the ischemic insult,
prior to terminal neuronal damage [25].
Yet, the effects of experimental neutropenia in rodent
stroke models range from decreased infarct volume [12, 62,
75] to little or no influence on lesion size [11, 44, 45], and
PMN mobilization from the bone marrow induced by gran-
ulocyte colony stimulating factor (G-CSF) does not worsen
clinical outcome in murine stroke models [83] or in a recent
clinical phase II trial (AXIS) [76]. Furthermore, although
some animal experiments targeting adhesion molecules
mediating the multi-step PMN migration across inflamed
microvessels have shown reduced infarct size [25], clinical
trials targeting PMN adhesion to endothelial ICAM-1 [9, 36,
47] or aiming at preventing PMN infiltration into the brain by
neutralizing the aMb2-integrin (CD11b/CD18) [54] have
failed to alleviate stroke severity, suggesting that the mode of
PMN action requires reassessment.
These discrepancies may reflect differences between the
pathogenic mechanisms involved in ischemia/reperfusion
in animal experiments and human stroke cases or, alter-
natively, could be linked to the assumption that PMNs use
ICAM-1 and b2-integrins to migrate into the brain paren-
chyma in reperfusion injury, as in other inflammatory
scenarios. This, however, has not been formally shown and
most PMN depletion studies or adhesion molecule blocking
studies after cerebral ischemia either did not assess PMN/
immune cell infiltration [15, 16, 67] or employed methods
that do not permit unequivocal identification of PMNs [37,
52, 61, 78]. A common problem has been the use of broad
specificity reagents such as the antibody clone, RB6-8C5,
targeting the Gr-1 antigen, which recognizes both Ly6G
and Ly6C and therefore stains PMNs and monocytes [35].
Similarly, myeloperoxidase staining identifies PMNs but
also monocytes and activated microglial cells [13]. Hence,
the use of such broad specificity reagents in flow cytometry
and/or immunohistochemistry inevitably results in an over-
estimation of PMN numbers. It is therefore important to
reassess the role of PMNs after cerebral ischemia using
more specific immune cell markers that are now available,
in particular in relation to their association with adhesion
molecules and their precise localization within the vascu-
lature and/or brain parenchyma.
That CNS vessels and neurons are functionally coupled is
well illustrated by the rapid response of neurons to focal
ischemia. Mechanistically, this is achieved by the neurovas-
cular unit (NVU), composed of a monolayer of specialized
endothelial cells (EC) interconnected by complex tight
junctions, the underlying endothelial basement membrane
(BM) and a second BM, known as the parenchymal BM as it
marks the border to the CNS parenchyma. Together with the
associated ensheathing layer of astrocyte endfeet, the
parenchymal BM defines the glia limitans [3, 64, 89], which is
structurally and functionally interconnected to the sur-
rounding neurons via astrocytes and microglia [14, 18]. With
the exception of capillaries, where endothelial and paren-
chymal BMs fuse to form one composite BM, in all brain
parenchymal vessels the endothelial and parenchymal BMs
are structurally and biochemically distinct entities, which
define the inner and outer limits of the perivascular space.
The NVU strictly controls immune cell emigration from
the blood vessel that requires a cascade of adhesive inter-
actions that are well described for neuroinflammation [32].
Due to the specialized structure of the NVU, leukocyte
entry into the brain parenchyma involves two differently
regulated steps: migration of leukocytes across the endo-
thelium into the perivascular space and progression across
the glia limitans into the brain parenchyma. In a murine
model of multiple sclerosis, experimental autoimmune
encephalomyelitis (EAE), induction of disease symptoms
occurs only upon immune cell penetration of the glia
limitans into the CNS parenchyma, whereas accumulation
of inflammatory cells within the perivascular space does
not translate into clinical disease [1, 8, 88], highlighting the
significance of the glia limitans as the effective border to
the CNS parenchyma.
While histological analyses of brain samples from
murine models of transient ischemia and human stroke
tissues have detected ‘‘inflammatory infiltrates’’ in the
brain [33, 68], there has been little attempt to either spe-
cifically identify PMNs using unique molecular markers or
to localize their precise position within the brain at defined
time points after ischemic stroke. This study presents a
collaborative investigation involving stroke researchers,
neuropathologists, and basic scientists to determine the
temporo-spatial relationship between immune cells and
blood vessel micro-architecture in the mouse and human
brain at early (acute) stages after ischemia using a panel of
markers for different subsets of myeloid cells, endothelial cell
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adhesion molecules, and the BMs of the NVU. We employ
the specific PMN marker, Ly6G [17], in immunohisto-
chemistry and in double and triple immunofluorescence
confocal microscopy to precisely localize PMNs in relation to
the cellular and BM components of the NVU, and to inves-
tigate correlations between PMN localization and altered
vessel permeability or expression of endothelial cell adhesion
molecules known to be involved in PMN rolling (P-selectin),
arrest and crawling (ICAM-1, ICAM-2) or diapedesis (PE-
CAM-1, CD99, JAM-A). An in vitro model for the BBB [82],
where PMN migration across an endothelial monolayer is
measured under physiological flow, is employed to investi-
gate the effects of transient oxygen–glucose deprivation
followed by reoxygenation. Our mouse and human data
highlight the need for a critical reappraisal of the precise site
of PMN action after stroke and molecular targets for therapies
to reduce reperfusion injury after stroke.
Materials and methods
Animals
151 male C57BL/6 and 129Sv 8–12-week-old mice were
employed (Table 1). Animal experiments were performed
according to Swiss (56/08) and German (G0383/09) legislation.
Transient middle cerebral artery occlusion (tMCAO)
Transient focal ischemia using the intraluminal filament
model was performed [26]. The left middle cerebral artery
was unilaterally occluded for 30, 60, and 90 min, after
which the filament was withdrawn and the tissue was rep-
erfused for varying lengths of time, resulting in the
following ischemia/reperfusion (I/R) protocols: I/R: 30
min/6, 12, 18, 24, 48, 72 h, 1 and 2 weeks; 60 min/6, 12, 18,
24, 48, 72 h, 1 and 2 weeks; 90 min/3, 18, 48 h). Motor–
sensory scores of the mice analyzing gait disturbances were
determined [10, 27] prior to termination of the experiments.
To account for experimenter variability, tMCAO was per-
formed in two independent laboratories and brains were
distributed to two separate laboratories for independent
immunohistological and immunofluorescence analyses. All
analyses included coronal sections through the core of the
lesion and adjacent penumbra (Bregma 0.50 mm), and
caudal to the ischemic area (Bregma -2.46 mm). Hence, all
analyses were standardized to the Stroke Therapy Aca-
demic Industry Roundtable (STAIR) criteria [34].
Flow cytometry
Inflammatory cells from ischemic ipsilateral and contra-
lateral brain hemispheres were isolated and stained as
described previously [28, 30]. Briefly, 6 anaesthetized
stroke mice in 3 independent experiments were perfused
with 297.4 mosm/l phosphate buffered saline (PBS), pH
7.4, to remove peripheral blood, their brains dissected, and
ischemic and contralateral cerebral hemispheres separated.
The tissue was then mechanically dissociated, digested
with collagenase VIII and DNAse I, filtered, and cells were
separated by centrifugation through a Percoll-gradient.
CD45high inflammatory cells and CD45intermediate microglia
were collected from the interphase and stained for Ly6G to
identify PMNs. Flow cytometry was performed using a
Table 1 Mouse tissues analyzed
Mouse
strain
Ischemia
(min)
Acute
reperfusion
Surgery
performed
Total
animals
analyzed
Animals
analyzed
by IH
Antibodies employedc Animals
analyzed
by IF
Antibodies employedc
C57Bl/6 30 6, 12, 18, 24,
48, 72 h
and
2 weeks
Berlin,
Bern
59 12 Leukocyte markers: CD45,
Gr-1, Ly6G, F4/80, CD11b,
Endothelial cell markers:
PECAM-1, VCAM-1,
ICAM-1, ICAM-2,
P-selectin
47a BM: Pan-laminin, laminin a5,
laminin a2, collagen IV
Leukocyte markers: CD45,
Ly6G, Ly6C, F4/80, CD11b,
CD41
Endothelial cell markers:
PECAM-1, VCAM-1,
ICAM-1, ICAM-2,
P-selectin.
C57Bl/6 60 6, 12, 18, 24,
48, 72 h
and
2 weeks
Berlin,
Bern
68 8 60a
C57Bl/6 90 3, 18, 48 h Berlin 9 3 6b
129 Sv 30 6, 72 h Berlin 6 3 3
129 Sv 90 3, 18, 48 h Berlin 9 3 6
a 18, 24, 48, 72 h and 2 week samples analyzed
b 18 h, 48 h analyzed
c See Table 2
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FACSCalibur; CellQuest (Becton–Dickinson) and FlowJo
(Tree Star Inc.) software were employed for data analysis.
Immunohistochemistry
Mice were perfused with 1 % paraformaldehyde (PFA) in
PBS, pH 7.4, their brains removed, embedded in TissueTek
(OCT Compound, Haslab) and frozen in a dry ice/isopentane
bath. Cryostat sections (6 lm) spanning the whole lesion area
were prepared, fixed in -20 C acetone and stained using a
three-step immunoperoxidase staining kit (Vectastain). Pri-
mary antibodies employed are listed in Table 2. Secondary
antibodies included biotinylated anti-rat and goat antibodies
and were consecutively incubated with avidin–biotin com-
plex (ABC) and peroxidase substrate solution (AEC,
Vectastain). Sections were assessed using a Nikon Eclipse
E600 microscope equipped with a digital camera.
Immunofluorescence
Immunofluorescence staining was performed on non-per-
fused, snap frozen tissues. 5-lm cryostat sections were fixed
in -20 C methanol. For confocal microscopy or 3D recon-
structions, tissues were fixed in 1.5 % PFA in PBS, pH 7.4,
for 1.5 h at 4 C, embedded in 1 % agarose in PBS, pH 7.4,
and 100-lm sections were prepared using a Zeiss vibratome.
Thick and thin sections were treated with PBS, pH 7.4, plus
1 % BSA before incubation at 4 C with primary antibody
(Table 2). Secondary antibodies included goat anti-rabbit and
donkey anti-rat IgG conjugated with Alexa Fluor 488 or
Table 2 Primary antibodies to extracellular matrix molecules and inflammatory cells
Molecule Antibody name/clone Marker IF/IHa Reference/source
Mouse
Pan-Laminin 455 All BMs IF, IH [80]b
Laminin a2 401 Parenchymal BM IF [77]b
Laminin a4 377 Endothelial BM IF [73]b
Laminin a5 405 Endothelial BM IF [80]b
Collagen IV – All BMs IF [86]c
P-Selectin Rabbit anti-P-selectin Activated endothelium IH [22], BD Pharmingen
ICAM-1 25ZC7 Endothelial adhesion molecule IF, IH [72], BD Pharmingen
ICAM-2 3C4 Endothelial adhesion molecule IH BD Pharmingen
VCAM-1 9DB3 Endothelial adhesion molecule IF, IH [29], BD Pharmingen
PECAM-1 Mec13.3 Endothelial junctions IH BD Pharmingen
Ly6G 1A8 PMNs IF, IH [17], BD Pharmingen
Ly6C AL-21 Monocytes IF [17], BD Pharmingen
Gr-1 RB6-8C5 PMNs, monocytes IF, IH [35], BD Pharmingen
F4/80 A3-1 Macrophages IF, IH BD Pharmingen
CD45 30G12
M1-9
All leukocytes IF
IH
BD Pharmingen
CD11b/Mac-1 M1/70 Microglia, monocytes, macrophages IF, IH BD Pharmingen
CD41 MWreg30 Platelets IF, IH BD Pharmingen
IgG 236 BA-9200 Murine IgG IF, IH BD Pharmingen
Antigen Antibody name/clone Marker IF/IHa Reference/source
Human
CD3 Polyclonal T lymphocytes IH Dako
CD15 C3D-1 PMNs, monocytes IH, IF Dako
CD45 2B11 All leukocytes IH, IF Dako
CD68 PG-M1 Activated macrophages, monocytes, microglia IH, IF Dako
LCA PD7/26 All leukocytes IH Dako
Hif1alpha NB 100-134 Hypoxia IH Novus biologicals
c.Caspase-3 Asp 175 Apoptotic cells IH Cell signaling
a Employed in IF immunofluorescence or IH immunohistochemistry
b Provided by L. Sorokin
c Kindly provided by K. von der Mark (Erlangen)
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Alexa Fluor 594 (Molecular Probes). Sections were exam-
ined using a Zeiss AxioImager microscope equipped with
epifluorescent optics and documented using a Hamamatsu
ORCA ER camera or with a Zeiss confocal laser scanning
system LSM 510meta. Images were analyzed using Volocity
5.2 software (ImproVision, Perkin Elmer).
To quantitate PMN numbers within vessels, in the peri-
vascular space or in the brain parenchyma, 100-lm coronal
sections throughout the entire brain were double immuno-
fluorescently stained for pan-laminin and Ly6G or CD45.
Ly6G? or CD45? cells located within or outside of the pan-
laminin staining were counted in optical sections throughout
the thick sections and expressed per 0.001 mm3 brain vol-
ume, and normalized to the proportion of the brain volume
occupied by vessels (i.e., total cells 9 vessel volume/total
brain volume). This calculation reflects the relative numbers
of PMNs accumulated in the different brain areas. Cells in or
associated with vessels were similarly expressed per m3 brain
volume, and subsequently normalized to the proportion of the
brain volume occupied by vessels. The cells in or associated
with vessels as a percentage of the total cell number were
calculated from these values. At least 5 fields of view were
analyzed/section, and at least 3 different thick sections were
analyzed within ischemic lesions from 2 to 3 mice. Statistical
analyses were employed to determine whether PMN numbers
were significantly higher in meninges, cortex or striatum
(one-way ANOVA), and to test for deviations from 100 %
Ly6G? cells in or in association with vessels (one-way
ANOVA).
In vivo blood–brain barrier permeability
tMCAO/24 h reperfusion mice were injected with 2 %
Hoechst 33258 (Calbiochem) plus 2 % Evans Blue (Alfa
Aesar) (total of 2 mice), or with a combination of 3 kDa
Texas Red-conjugated Dextran and 10 kDa FITC-conjugated
Dextran, 100 lg each (Molecular Probes) (total of 2 mice).
The dyes were allowed to circulate for 30 min and 15 min,
respectively, before sacrificing the mice. Only dextran-
injected mice were perfused with PBS, pH 7.4, followed by
4 % formaldehyde/PBS, pH 7.4, and brains were frozen.
Brains from Hoechst/Evans blue-injected mice were snap
frozen in TissueTek in a dry ice/isopentane bath. Cryosec-
tions were analyzed for possible extravasation of tracers from
microvessels of the stroke-afflicted hemisphere, with
extravasation across the fenestrated endothelium of the cho-
roid plexus serving as internal positive control.
In vitro blood–brain barrier model
Mixed glial cell cultures enriched in astrocytes [41] were
cocultured with primary mouse brain microvascular
endothelial cells (pMBMECs) [82] and subjected to
oxygen and glucose deprivation (OGD) by adding glu-
cose- and serum-free medium and keeping the cells
under anoxic conditions using GasPack EZ bags (Bec-
ton–Dickinson) for 4 h. For normoxic controls, cells
were exposed to serum-free DMEM containing glucose
during the OGD period. 4 h IL-1b (20 ng/ml) stimulated
pMBMECs under normoxic conditions were also
employed. After 20 h of reoxygenation, the endothelial
monolayer, grown on an insert (Millicell CM, Millipore),
was placed on a flow chamber and highly purified bone
marrow derived PMNs were perfused over the pMB-
MECs. PMNs were allowed to accumulate for 4 min at
low shear stress (0.25 dyn/cm2); the subsequent PMN
interaction with pMBMECs under physiological shear
stress (1.5 dyn/cm2) was recorded with an inverted
microscope (AxioObserver Z1, Carl Zeiss) at 209
magnification (objective EC Plan Neofluar 9 10/0.3).
Time-lapse videos were created by taking one image
every 20 s over a 20-min period (AxioVision, Carl
Zeiss). Image J software was used for the analysis of the
movies. pMBMECs were also immunostained for ICAM-
1 and ICAM-2 and counter-stained with Hoechst dye to
show the cell nuclei.
Human samples
Brain autopsy and biopsy material of twenty-five stroke
patients (Supplementary Table 1) was analyzed by H&E,
chloracetate esterase, myeloperoxidase, immunohistochem-
ical, or immunofluorescent (Table 2) staining in accordance
with the local ethics committee. The DNA-binding dye TO-
PRO-3 (Invitrogen, Germany) was employed to mark all
nuclei. Infarct staging was performed according to the 3-stage
stroke classification frequently used in neuropathological
diagnostics, which was first described in detail by Hugo Spatz
in 1939 [81], and of which cellular reactions have been more
sophisticatedly deciphered over the years (for review see
[24]). Histopathologically, the infarct lesions were classified
into stage I (acute), stage II (subacute), and stage III (chronic).
Human brains were fixed in 4 % phosphate-buffered form-
aldehyde; pH 7.4, embedded in paraffin, and 3-lm sections
were analyzed. Immunohistochemical single and double
stainings were performed using the Benchmark and Discov-
eryXT immunohistochemistry systems (Ventana/Roche,
France) and counterstained with hematoxylin. Primary anti-
bodies employed are listed in Table 2. Immunofluorescence
images were analyzed and recorded using a Leica TCS SP
confocal microscope, and the EZ-C1 software. After
recording, digital images were further processed and adjusted
for brightness, contrast, and colour balance with ImageJ
(NIH).
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Results
Since C57BL/6 mice develop larger infarcts after tMCAO
than Sv129 mice [59, 66] and Sv129 mice exhibit higher
levels of circulating PMNs compared with C57BL/6 mice
[65], we studied tMCAO in both mouse strains in parallel
(Table 1).
Temporal and spatial appearance of polymorphonuclear
granulocytes (PMNs) in the brain after transient middle
cerebral artery occlusion (tMCAO)
To assess effects of ischemia duration on immune cell
recruitment, C57BL/6 mice were subjected to tMCAO for
30, 60, and 90 min, and Sv129 mice to 30 and 90 min
(Table 1). Since the lesion matures over time, reperfusion
times of 6, 12, 18, 24, 48, 72 h, 1 and 2 weeks were
examined to cover the entire acute phase of reperfusion
injury in all tMCAO scenarios (Table 1). Tissue damage
caused by these tMCAO times is well characterized, with
30 min causing mainly selective nerve cell injury and as-
trogliosis in the striatum, and 60 and 90 min causing
selective nerve cell injury involving large parts of the MCA
territory [27, 50]. Immunohistological and immunofluo-
rescence analyses for the presence of various leukocyte
populations were investigated in coronal brain sections as
described above using the antibodies listed in Table 2.
There were no overt differences between C57BL/6 and
Sv129 mice in the time point of first appearance or the dis-
tribution of CD45? immune cells in the ischemic brains.
Flow cytometry (Fig. 1a) and immunohistochemistry
(Fig. 1b) revealed Ly6G? PMNs to be the first cell type
detectable in the ipsilateral hemisphere, independent of the
duration of ischemia. However, the absolute time point of
their appearance and how long they were detectable varied
with occlusion length. The appearance of Ly6G? PMNs was
monophasic, with sparse appearance of PMNs at 12 h of
reperfusion in 30 and 60 min tMCAO samples and at 3 h in
90 min tMCAO, in all cases peaking at 18–24 h (Fig. 1a).
Surprisingly, immunohistochemistry localized Ly6G?
cells predominantly to the leptomeningeal space of the
ischemic hemisphere either confined within vessel lumina or
closely associated with vessel surfaces regardless of MCA
occlusion time (Fig. 1b). To a lesser extent, PMNs were also
present in the leptomeninges of the contralateral hemisphere.
Additional PMNs were detected in close association with
arterioles in the motor–sensory cortex (Fig. 1b), and only
isolated PMNs occurred in the striatum within the lesion core,
principally in association with tears in the tissue (Fig. 1b).
The latter was enhanced in 60 and 90 min occlusions where
tissue integrity was severely compromised.
The only site where considerable numbers of PMNs
were found outside of blood vessels was in the
subarachnoid space covering the surface of both brain and
optic nerves, remote from the ischemic area. PMNs were
not observed in the adjacent cortical layers indicating their
failure to penetrate the glia limitans. In accordance with
previous reports [38], some PMNs were detected in the
parenchyma of the lateral preoptic area (LPO) (Supple-
mentary Fig. 1). As the LPO is not directly irrigated by the
MCA these effects may be due to an indirect occlusion of
the anterior medial striate artery that originates from the
MCA [23] and irrigates dorso-lateral aspects of the cau-
date–putamen. The ophthalmic artery is derived from the
internal carotid artery (ICA) that travels ventrally to the
optic nerve within the optic canal and is enveloped within a
dural sleeve of the optic nerve [40]. As the ICA is occluded
in the tMCAO model employed, this probably accounts for
the meningeal PMN accumulation observed around the
optic nerve. Importantly, both the LPO and the meningeal
infiltration around the optic nerve would skew flow
cytometry or biochemical analyses for the presence of
PMNs in the brain after experimental ischemic infarct.
Ly6C?CD11b? monocytes were scarce and detectable
at 24–48 h reperfusion in 30 and 60 min tMCAO; isolated
CD45?CD11b?F4/80? macrophages were detected at
48 h, peaking at 72 h reperfusion. In contrast to Ly6G?
PMNs, isolated Ly6C?CD11b? monocytes were also
found within the brain parenchyma at 24 h reperfusion, and
at later stages also CD45?CD11b?F4/80? macrophages
(Supplementary Fig. 2a, b).
Polymorphonuclear granulocyte (PMN) localization
within the neurovascular unit (NVU)
Due to the limitations of immunohistochemistry and con-
ventional immunofluorescence microscopy in localizing
Fig. 1 Localization of PMNs in the ischemic brain following 60 min
of tMCAO and 18 h and 24 h reperfusion. a Inflammatory cells were
isolated from the ipsilateral ischemic and contralateral hemisphere of
6 mice following 60 min tMCAO and 24 h reperfusion by enzymatic
digestion and density gradient centrifugation, and analyzed by flow
cytometry. Using Forward (FSC) and Side Scatter (SSC) profiles
inflammatory cells were separated according to size (FSC) and
granularity (SSC), respectively, and displayed in a dot blot. PMNs are
characterized by a high SSC signal due to their high content of
granules. Such a population was only found in the ipsilateral and not
in the contralateral hemisphere. Positive Ly6G immunoreactivity of
the scatter gated population, as depicted in the histogram (right side),
confirmed their identity as PMNs. b Schematic representation of the
two planes of the brain examined (X Bregma 0.50 mm, Y Bregma
-2.46 mm) and corresponding coronal sections showing areas
analyzed. Immunohistochemistry of sections from 60 min tMCAO
and 24 h perfusion for CD45 and Ly6G reveal distribution of total
leukocytes and PMNs, respectively, in the meninges (Mng), motor–
sensory cortex (Ctx), and striatum (Str). The majority of cells were
detected either intra- or perivascular in the meninges (arrows) and the
penumbral cortex (arrowheads) and the cells comprised mainly
Ly6G? PMNs. Bar is 50 lm
c
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cells to defined layers within the NVU, fluorescently
stained 100-lm sections were analyzed by confocal
microscopy to obtain optical sections and 3D reconstruc-
tions. Thirty and 60 min tMCAO at 18 and 24 h
reperfusion were examined. Sections were double stained
with Ly6G or CD45 and pan-laminin antibody which rec-
ognizes the majority of the laminin isoforms, or a specific
marker of the endothelial BM, laminin a5, permitting
localization of PMNs within vessel lumina or in the peri-
vascular space, as defined by the endothelial and
parenchymal BMs (termed vessel associated), or outside of
the endothelial and parenchymal BMs and hence within the
CNS parenchyma (termed intraparenchymal) (Fig. 2a, b).
Figure 2c illustrates that most CD45? leukocytes and,
specifically, Ly6G? PMNs localized within the lumina of
vessels of 30–40 lm diameter, predominantly representing
arterioles, in the meninges and cortex, and did not occur in
the ischemic core. Total numbers of CD45? and Ly6G?
cells in the meninges, cortex, and striatum were counted
and expressed per mm3 brain volume, and subsequently
normalized to the proportion of the brain volume occupied
by vessels, permitting assessment of the relative numbers
of PMNs accumulated in the different brain areas, reveal-
ing an overall low number of PMNs and their tendency to
localize to the meninges (although this was not statistically
significant) (Fig. 2d). At 18 and 24 h reperfusion, numbers
of CD45? and Ly6G? cells did not differ significantly and
data shown in Fig. 2d are for Ly6G? cells. Cells associated
with vessels were similarly expressed per mm3 brain vol-
ume, and subsequently normalized to the proportion of the
brain volume occupied by vessels. The percentage of vessel
associated Ly6G? cells was calculated using these nor-
malized values (Fig. 2d). Statistical analyses revealed the
absence of significant deviations from 100 % cells asso-
ciated with vessels in the striatum (mean 90 % ± 7;
P = 0.866), meninges (mean 94 % ± 4; P = 0.766), and
cortex (mean 89 % ± 7; P = 0.56) at both 18 and 24 h
reperfusion, regardless of occlusion time (data for 60 min
tMCAO, 24 h reperfusion is shown in Fig. 2d). PMNs
found were also not associated with CD41? platelets
(Fig. 3) or erythrocytes, indicating the absence of any
hemorrhagic transformation.
Polymorphonuclear granulocyte (PMN) accumulation
is not associated with upregulated endothelial adhesion
molecule expression, platelet aggregation or vascular
permeability
PMN accumulation within blood vessel lumina suggests
endothelial cell activation or aberrant endothelial cell
physiology. To investigate potential correlations between
PMN localization and local altered expression of endo-
thelial cell adhesion molecules implicated in PMN
adhesion to or migration across the vascular wall in
inflammation, specifically P-selectin, ICAM-1, ICAM-2,
and PECAM-1 were analyzed in 60 min tMCAO samples
at 6, 12, 18, 24 h of reperfusion using confocal immuno-
fluorescence microscopy. No differences in staining
patterns or intensity were observed for PECAM-1 between
lesioned and non-lesioned hemispheres (not shown). As
previously reported, immunofluorescence staining for vas-
cular ICAM-1 and VCAM-1 was more extensive in the
ischemic area [16, 51, 63], principally in vessels in the
meninges and cortex (Fig. 3). Staining for P-selectin,
which is not constitutively expressed in the brain paren-
chyma [22], was enhanced in isolated vessels in the
penumbra at 12 h and 24 h reperfusion (Fig. 3). Despite
enhanced immunofluorescence staining for P-selectin,
ICAM-1 and VCAM-1 in many vessels of the lesioned
hemisphere compared to the non-lesioned hemisphere,
there was no strict spatial correlation of increased adhesion
molecule expression with sites of vascular PMN accumu-
lation and[90 % of the vessels showing increased VCAM-
1 and ICAM-1 staining were not associated with Ly6G?
cells (Fig. 3) nor was PMN localization associated with
platelet aggregates, as determined by double immunofluo-
rescence staining for Ly6G and CD41 (Fig. 3). Rather,
platelet aggregations were localized mainly to the lumina
of dilated vessels both in the absence and presence of
PMNs (Fig. 3). Finally, neutrophil extracellular traps
(NETs), which have been reported to trap PMNs within
Fig. 2 Localization of neutrophils in the neurovascular unit. a Con-
focal microscopy of a thick section (100 lm) double stained for
laminin a5, showing the inner endothelial BM, and laminin a2,
showing the outer parenchymal BM, and b schematic representation
of the constituents of the NVU. Relative sizes and numbers of the
NVU constituents are not to scale. MØ refers to macrophages and DC
is dendritic cells. c Schematic representation of the plane of the brain
examined (X Bregma 0.50 mm) and corresponding coronal section
showing areas analyzed (striatum Str, meninges Mng and motor–
sensory cortex Ctx). Corresponding confocal microscopy of thick
sections from plane X of 60 min tMCAO, 24 h reperfusion, double
stained with antibodies to pan-laminin, to mark all BMs, and CD45,
or to laminin a5, as a marker of the endothelial BM, and Ly6G, reveal
localization of total leukocytes and PMNs mainly in association with
arteries or large arterioles (outer panels) and veins (middle panel).
Images shown are from area Ctx. d Analyses of individual Z stacks
permitted localization of Ly6G? PMNs within vessel lumina or
between the endothelial and parenchymal BM (vessel associated), or
intra-parenchymally. Staining shown is for an arteriole. Graphs to the
right show total Ly6G? PMN numbers/0.001 mm3 brain volume
normalized to the proportion of the brain volume occupied by vessels
in Str striatum, Mng meninges and Ctx cortex. Normalized Ly6G?
PMN numbers associated with vessels in the different areas are
expressed as percentages of the normalized total Ly6G? cell numbers
and show no statistically significant differences from 100 % cells
associated with vessels (P values 0.56–0.86). Data shown are
mean ± SEM from 2 to 3 mice. NS is no statistically significant
difference. Bars in c and d are 40 lm
c
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vessels lumens, were investigated by staining for DNA as
previously described [85], revealing the absence of vas-
cular NET formation in any of the samples analyzed.
Importantly, PMN accumulation within blood vessels
was not associated with local changes in vascular perme-
ability as shown by triple staining for murine
immunoglobulin (IgG), Ly6G and pan-laminin (Supple-
mentary Fig. 3a). In general, the presence of IgG in the
brain parenchyma was detected in 40 % of all 60 min
tMCAO 18 h and 24 h samples, mostly observed around
larger vessels in the cortex, and was not correlated with
sites of Ly6G? PMN accumulation (Supplementary
Fig. 3a). To further address possible in vivo poststroke
BBB leakage, 60 tMCAO/24 h reperfusion mice were
intravenously injected with either Evans Blue and Hoechst
33258 or 3 kDa Texas Red-Dextran and 10 kDa FITC-
Dextran prior to sacrifice. In addition to staining of endo-
thelial cell nuclei, Hoechst 33258 labelled nuclei of
neurons in the lateral preoptic area (LPO) of the ischemic
hemisphere. Extravasation of Evans blue (Supplementary
Fig. 3b) or labelled dextrans (data not shown) was fur-
thermore observed only around some dilated vessels within
the striatum or around focal arterioles in the penumbra in
the ischemic hemisphere.
Oxygen and glucose deprivation fails to induce
polymorphonuclear granulocyte (PMN) extravasation
across the blood–brain barrier under physiological flow
in vitro
Our observations suggest that in contrast to inflammatory
stimuli, ischemia/reperfusion fails to induce the signals in brain
endothelial cells required to mediate the extravasation of cir-
culating PMNs into the brain parenchyma. To mimic PMN
interactions with the BBB under physiological flow (1.5 dyn/
cm2) after ischemia/reperfusion in vitro, glial cells in coculture
with primary mouse brain microvascular endothelial cells
(pMBMECs) were exposed to normoxic conditions or 4 h of
oxygen and glucose deprivation (OGD) followed by 20 h of
reoxygenation. For live cell imaging, the endothelial mono-
layer was placed in the flow chamber and highly purified bone
marrow derived PMNs were perfused over the pMBMECs.
The dynamic PMN interaction with the pMBMECs was
recorded under constant flow for 20 min. Comparisons were
made with cocultures treated with or without IL-1b under
normoxic conditions. While PMNs were able to arrest, crawl,
and diapedese across the IL-1b treated pMBMECs, pMB-
MECs exposed to OGD/reoxygenation induced brief PMN
arrest and crawling but did not result in PMN diapedesis across
Fig. 3 Endothelial adhesion molecules or platelet accumulation are
not sufficient for Ly6G? PMN extravasation in vivo. Data shown are
for 60 min tMCAO and 24 h reperfusion (16 lm sections). Double
immunofluorescence staining for Ly6G and intercellular adhesion
molecule-1 (ICAM-1) and 2 (ICAM-2), vascular endothelial cell
adhesion molecule (VCAM-1), or P-selectin showed some upregula-
tion of adhesion molecules in cortical and meningeal microvessels of
the ischemic hemisphere but no strict spatial correlation with Ly6G?
PMNs which localize intraluminally (arrows), perivascularly (arrow-
head) or in the meningeal compartment (asterisk). Immunofluorescence
staining for CD41? platelets and Ly6G revealed that platelet accumu-
lation in vessels was not associated with the localization of PMNs. Bars
are 40 lm
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the endothelium, thus resembling non-stimulated normoxic
conditions (Fig. 4a, b; Supplementary videos 1–3). Surpris-
ingly, OGD/reoxygenation upregulated cell surface expression
of adhesion molecules, as exemplified by the increased
immunostaining for ICAM-1 on the pMBMECs (Fig. 4c),
which was similar to that induced by IL-1b treatment. These
data indicate that although ICAM-1 is upregulated on brain
endothelium under ischemic conditions in vitro and in vivo,
ischemia/reperfusion fails to induce the sum of traffic signals in
brain endothelial cells required to promote PMN transmigra-
tion across the endothelial monolayer.
Localization of polymorphonuclear granulocytes
(PMNs) in human stroke specimens
To determine whether our findings were relevant to human
stroke, 25 specimens [24 autopsy cases including 17 pure
acute stroke (stage I, Fig. 5) and 8 mixed (apart from stage
I also showing stage II or III infarct regions in other CNS
areas) and one biopsy specimen (Supplementary Table 1)]
were examined by immunohistochemistry and immuno-
fluorescence microscopy as described for the mouse
tMCAO samples. As anti-human Ly6G antibodies are not
available, morphology together with CD15? immuno-
staining (which mainly recognizes PMNs and a subset of
monocytes) and enzyme histochemistry for myeloperoxi-
dase and chloracetate esterase were employed to identify
PMNs. Very few PMNs were detected in both early infarct
stages (stage I) and at stages of resorption (stage II)
(Supplementary Fig. 4), with the majority of the PMNs
being localized either within the lumen of blood vessels
(Fig. 5d) or in the perivascular space between the endo-
thelial and parenchymal BMs visualized using a pan-
collagen type IV antibody (data not shown). Absence of
Fig. 4 PMN interaction with endothelium in an in vitro blood–brain
barrier model. PMN interaction with pMBMECs under normoxic,
ischemic (OGD ? reox) or IL-1b stimulated conditions under
physiological flow (1.5 dyn/cm2) was recorded for 20 min and the
dynamic behaviour of arrested PMNs was analyzed. a The number of
PMNs arrested on pMBMECs counted per field of view (FOV).
b Proportions of PMNs that were stationary, crawling, undergoing
diapedesis or detachment from pMBMECs. PMNs that remained
immobile on the monolayer were defined as ‘Stationary’, PMNs that
polarized and crawled on the monolayer but did not diapedese across
the endothelial monolayer were described as ‘Crawling’, PMNs that
crawled until they found a suitable site for diapedesis were defined as
undergoing ‘Diapedsis’, and PMNs that detached during the video
acquisition time were termed ‘Detachment’. Data in a and b are
mean ± SD, n = 3. c Immunofluorescence staining of pMBMECs for
ICAM-1 and ICAM-2 under normoxic, ischemic, and IL-1b stimu-
lated conditions shows upregulation of ICAM-1 under both, ischemic
and IL-1b stimulation, ICAM-2 staining remains unaffected. Endo-
thelial cells are counter-stained with Hoechst dye to show the cell
nuclei. Bar 50 lm
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granulocytic infiltration into the CNS parenchyma was
especially noted in very acute stroke lesions (\48 h), even
though this has been proposed to be the main time frame
for PMNs to invade infarcted brain tissue after CNS
ischemia. Analyses of samples of such \48 h infarct
lesions revealed the appearance of cells morphologically
resembling PMNs not only in vessels but also in the CNS
parenchyma; however, CD15 staining was restricted to
cells within vessel lumina (Fig. 5d). Indeed, upon careful
examination multiple cells showing PMN morphology in
the CNS parenchyma were found to be positive for cleaved
caspase-3 (Fig. 5e), suggesting that they represent apop-
totic bodies, which morphologically are easily confused
with PMNs due to their fragmented nuclei. Already at this
early infarct stage, a low amount of extravasated CD68?
monocytic cells was observed (Fig. 5f). Using this com-
bination of CD15 staining, together with morphology and
enzyme histochemistry for myeloperoxidase and chlorac-
etate esterase (not shown) to identify PMNs in very early
infarct lesions, rare infiltration in the subarachnoid and the
subpial space, in the cortical layers I and II (not shown) and
the Virchow-Robin space was observed. No PMNs were
detected in the inner cortical layers or in the infarct center
and border zones. Even at later stages after infarction
PMNs remained confined to vessel lumina, despite exten-
sive presence of CD45-positive leukocytes (not shown)
which mainly consisted of CD163-negative (not shown)
and CD68-positive macrophages and activated microglia
and a moderate fraction of CD3-positive T-cells (while
CD20-positive B-cells were virtually absent) and aberrant
dilated appearance of vessels (Supplementary Fig. 4),
indicative of ischemia.
Discussion
By bringing together stroke researchers, neuropathologists,
cell biologists, and neuroimmunologists specialized on the
cellular and extracellular matrix components of the NVU
and immune cell penetration of the NVU, we have been
able to comprehensively investigate the in vivo PMN
localization after ischemic stroke in mouse and human
samples. Our data support an early appearance of PMNs
after ischemic stroke in both mouse tMCAO and in human
Fig. 5 Histopathology of human acute stroke specimens (Stage I).
a H&E staining of human stage I stroke specimen demonstrating
demarcation of the ischemic core from the penumbra (arrows);
b H&E staining (high magnification of a) showing the presence of
eosinophilic neurons indicating an early ischemic neuronal damage;
c At the infarct border zone, eosinophilic neurons (arrowhead, as
depicted in Fig. 5b) are surrounded by glial cells showing severe
hypoxic changes (arrows) as indicated by the strong expression of
hypoxia-inducible factor-1 alpha (Hif1alpha); d CD15 immunohisto-
chemistry indicating that PMNs are primarily located within blood
vessels in acute human stroke lesions; e characterization of cells with
histomorphological features of PMNs within the CNS parenchyma:
while intravascular cells with PMN-like morphology (as seen in
Fig. 5d) were strongly CD15-positive, intraparenchymally located
cells exhibiting PMN-like morphology and being CD15-negative are
strongly positive for cleaved caspase-3 (arrow) indicating that these
cells undergo apoptosis; f CD68-positive cells of the monocytic
lineage are mainly located in the perivascular space or within the
brain parenchyma. Data shown are from a 75-year-old male patient
suffering from an acute right parietal ischemic infarct (for details see
Supplementary Table 1)
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samples, as shown by others [21], but contrary to previous
concepts our data show that PMNs are (1) limited in
number, (2) associate with vessel lumina or the perivas-
cular and leptomeningeal space, and (3) do not strictly
correlate with either platelet aggregates, sites of increased
vessel permeability, or sites of enhanced expression of
endothelial adhesion molecules known to be required for
PMN extravasation in inflammation. Studies of CNS
autoimmune inflammation have shown that localization of
immune cells within the leptomeningeal and perivascular
space is not sufficient to induce disease symptoms [1, 8].
Rather, penetration of the parenchymal BM is required
before access to CNS parenchyma and induction of path-
ological processes is possible [1, 84]. Hence, the
localization of PMNs to the vasculature early after ische-
mic stroke necessitates reassessment of their role in stroke.
Although some adhesion molecules, such as VCAM-1,
were upregulated on vessels in the ischemic hemisphere,
the expression of adhesion molecules was heterogeneous
with some vessels having low and others high expression
levels, and there was no spatial correlation with PMN
accumulation within vessels or in the perivascular space.
While previous studies have investigated adhesion mole-
cules in ischemic stroke showing results similar to those
obtained here [16, 51, 63], no previous study has correlated
in vivo adhesion molecule expression with localization of
PMNs. Indeed, most studies have involved flow cytometry
or myeloperoxidase expression in excised brains to quan-
tify PMNs while adhesion molecules were analyzed by
immunofluorescence microscopy on tissue sections, which
led to the false conclusion that the two are correlated. This
has also been the justification for employing mice lacking
ICAM-1, or the use of function blocking antibodies tar-
geting adhesion molecules in MCAO experiments, which
have produced variable results [9, 36, 47]. Normally,
extravasation of PMNs during inflammation occurs at the
level of postcapillary venules [69] and involves E- and
P-selectin-mediated rolling on the endothelial cell surface,
and subsequent ICAM-1 mediated arrest and diapedesis
across the endothelial cell monolayer [31, 55]. The absence
of a spatial correlation between upregulated expression of
endothelial P-selectin, VCAM-1 and ICAM-1 and vascular
sites of PMN accumulation in the tMCAO samples sug-
gests the absence of the complete cascade of these events
and that the mode of endothelial activation that occurs after
ischemic stroke is not sufficient to trigger PMN extrava-
sation into the brain parenchyma. This is supported by the
in vitro studies involving pMBMECs, which demonstrated
that while OGD/reoxygenation can upregulate endothelial
ICAM-1 this was not sufficient to support transmigration of
PMNs across the pMBMEC monolayer. In addition, the
failure of those few PMNs that enter the perivascular space
to penetrate into the brain parenchyma proper also reflects
the absence of the molecular signals required for their
invasion into the CNS as observed in inflammation.
The concept that the brain parenchyma is a tissue that is
unique in its resistance to leukocyte diapedesis has previ-
ously been suggested by others, who have shown that even
direct intracerebral injection of chemotactic cytokines that
are sufficient to induce PMN extravasation into other tis-
sues fail to trigger PMN extravasation into the brain
parenchyma [4]. Thus, PMN migration from the blood
stream across the BBB and the glia limitans into the brain
parenchyma requires more than presence of chemotactic
factors and induction of leukocyte adhesion to cerebral
endothelium.
The precise molecular mechanism involved in PMN
accumulation within vessels observed in the current study
is not clear and we can only speculate on the molecules
involved. The fact that PMNs accumulated in larger ves-
sels, mainly arterioles, further supports the hypothesis that
the molecular mechanism/s involved are distinct from
those described above for postcapillary venules. A recent
study involving transient ligation and reperfusion of the
vena cava reported a similar PMN accumulation that was
not associated with expression of the classical adhesion
molecules or platelets, but rather with DNA NETs released
by PMNs and resulting in their aggregation [85]. This was
not the case here, as NETS were not detected in any of the
tMCAO samples. However, it is possible that hypoxia or
changes in blood flow, resulting from vessel occlusion,
alters the expression of as yet unidentified adhesion mol-
ecules, either upregulating molecules that promote PMN
adherence but also downregulating anti-adhesive mole-
cules. The endothelial glycocalyx, composed largely of
glycosaminoglycans carrying highly negatively charged
heparin sulfate chains, is known to repel cells in the cir-
culation, and the depletion of heparan sulfate chains
significantly enhances immune cell adhesion [57, 58]. As
the glycocalyx changes with blood flow [42], it is con-
ceivable that it may present part of a novel adhesion
mechanism in larger vessels. This is supported by the
recent identification of a role for myeloperoxidase, released
from PMNs, in charged interactions between PMNs and the
gylcocalyx of endothelium which promotes PMN adher-
ence [53]. While this is a promising field, the role of charge
molecules such as cell surface glycans has rarely been
considered in immune cell recruitment, mainly due to the
complex chemistry associated with their analysis.
Importantly, our data provide evidence that previous
studies have overestimated PMN contribution to stroke
because of the methods used for their identification and
shed new light on previous animal studies and clinical
trials. The largest majority of previous studies have focused
on permanent MCAO, rather than the temporary MCAO
employed here, which may be one reason for the
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comparatively low PMN numbers detected in our study. In
addition, the high numbers of PMNs detected in the lep-
tomeningeal areas, especially surrounding the optical nerve
as detected here but also reported previously [38], suggest
that previous studies solely based on flow cytometry or
enzymatic assessment of PMN infiltration into the brain are
likely to have equated these findings with number of PMNs
present within the ischemic brain parenchyma. Myeloper-
oxidase, commonly used as a PMN marker, is expressed by
PMNs, monocytes and activated microglia present in the
ischemic brain [13], while the Gr-1 antibody (clone RB6-
8C5), frequently used to identify PMNs, recognizes both
Ly6C and Ly6G expressed by monocytes and PMNs,
respectively [35]. The use of these tools would therefore
inevitably lead to an over-estimation of PMNs. Only few
studies have attempted to localize PMNs in the brain
parenchyma at defined times after MCAO, including that of
Garcia and Kamijyo [38], who employed electron
microscopy of permanent MCAO in rats. Consistent with
our data, the majority of the PMNs were found in vessels,
and while rare isolated PMNs were detected outside of the
endothelial layer, the magnifications shown are too high to
definitively state that the PMN is in the brain parenchyma
(and not in the perivascular space) nor do they provide
evidence for neuronal death in the close vicinity of PMNs,
rather isolated images of damaged neurons are shown. The
concept that PMNs contribute to reperfusion injury at early
stages after ischemic stroke has led to clinical trials tar-
geting PMNs to minimize infarct volume, most of which
have not been successful [25]. While this may in part be
attributable to factors such as patient cohort size or
demography, or adverse effects of the PMN targeting
strategies [36], the data presented here suggest that the role
of PMNs in ischemic stroke remains unclear and needs
further investigation before their consideration as a rele-
vant therapeutic target.
The PMN specific anti-Ly6G antibody (clone 1A8)
employed here [17], in conjunction with immunofluores-
cence staining for defined markers of the vascular
basement membranes and confocal analyses have permit-
ted a reliable identification and localization of PMNs in
ischemic brain sections, and highlight the importance of
supplementing quantitative analyses of ischemic tissue by
in vivo localization studies. However, the choice of such
in vivo imaging technologies is also crucial; while intra-
vital microscopy (IVM) via a cortical window has been
used to assess in vivo leukocyte–endothelial cell interac-
tions in the ischemic brain [5, 48], the working depth
achievable is limited and in addition only meningeal
postcapillary venules run parallel to the surface of the
skull, whereas cortical postcapillary venules are orientated
perpendicularly to the surface of the brain and the focal
plane [46, 71]. Hence, it is impossible to discern
leukocyte–endothelial interactions in cortical postcapillary
venules as this requires tracing of leukocytes over a defined
period along a certain vessel length. As meningeal and
parenchymal blood vessels differ from one another in
several aspects [64], including the absence of a glial en-
sheathment in leptomeningeal vessels [70] and the
constitutive expression of P-selectin in meningeal but not
parenchymal microvessels [6], studying meningeal vessels
in stroke is not a substitute for cortical microvessels. Given
our detection of a high number of PMNs in the leptome-
ninges, intravital imaging of such areas might overestimate
PMN recruitment into the brain after stroke. Taken toge-
ther, this suggests that confocal microscopic analysis of
thick brain sections using defined markers of immune cells
and the borders of the NVU is, at present, the most efficient
mode of assessing immune cell infiltration after ischemic
stroke in experimental models.
The analysis of human autopsy samples corroborated the
observation that PMNs rarely occur in the brain paren-
chyma early after stroke. Clearly, it is impossible to prove
that the patient samples analyzed had undergone reperfu-
sion after the vessel occlusion/brain ischemia and to define
this histologically. However, spontaneous reperfusion is a
frequent phenomenon in clinical stroke, which may also
occur in parts of the ischemic area, and even in patients
receiving thrombolysis often some brain tissue undergoes
infarction despite reperfusion [43, 74]. Hence, a spectrum
ranging from no reperfusion to different times and extent of
reperfusion are likely in such autopsy samples, validating
the comparison with the mouse tMCAO data. The question
therefore arises how the concept that PMN leukocytes
strongly infiltrate the brain parenchyma within the first
24 h after onset of brain infarction has gained access into
widely accepted neurological and neuropathological text-
books [33]. Several studies have defined the time frame of
PMN detection in the brain after ischemic stroke, mainly
using SPECT and CT scan analyses of injected tracer
immune cells [2, 87]. Already these studies revealed con-
flicting results about when and over which time period
PMNs are detectable in the brain; however, the discrep-
ancies were attributed to the injection of mixed leukocytes
[87] versus purified PMNs prior to SPECT [2]. While
SPECT permits high temporal resolution of such tracer
cells, it has poor spatial resolution and does not permit the
distinction between PMNs within or outside the confines of
the NVU. A second point of conflict might be the extent of
foci of fresh bleedings in mainly ischemic infarction. Even
selected pictures from classical textbooks [33], employed
as evidence for PMN entry into the brain parenchyma after
ischemic stroke, depict fresh foci of hemorrhages and
associated leakage of various cellular populations includ-
ing erythrocytes and monocytes, indicative of more severe
vascular disruption. Therefore, vascular disruption might
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be a very logical explanation for the detection of PMNs in
the CNS parenchyma in stroke cases accompanied by
hemorrhages. However, these findings differ considerably
from classical forms of purely ischemic stroke lesions.
Finally, pioneering studies addressing the role of PMNs in
stroke did not have access to the complex panel of
immunocytochemical markers, available now, to precisely
define cell types and their localization in relation to the
cellular and BMs layers of the NVU, but rather relied
mainly on classical histomorphological examination [38,
79]. These drawbacks might constitute problems if sections
are assessed by histology only where PMNs may be con-
fused with different stages of apoptotic figures, which also
frequently occur in hypoxic-ischemic brain lesions, due to
their similar morphology. While isolated studies exist, like
that of Lindsberg et al. [56], which included early human
stroke samples without secondary hemorrhages showing
CD15-positive cells in the lesioned CNS, even these state
that granulocytes in early infarction are mostly found
within the intravascular space and typically aggregate at
the walls of CNS vessels and are, therefore, in accordance
with our findings. However, Lindsberg et al. admit that a
systematic evaluation of morphological details such as
whether granulocytes were still surrounded by a capillary
lumen was not possible in their cohort.
In conclusion, our data indicate that PMNs do not gain
access to the brain parenchyma early after ischemic stroke
and highlight the vascular compartment of the NVU rather
than neurons, as previously suggested also by others [20],
as the site of potential PMN action.
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